Summary

● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.


Strengths

● 

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.29 for the 2021 fiscal year.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.


Weaknesses

● 

● The company has insufficient levels of profitability.

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 103.17 times its estimated earnings per share for the ongoing year.

● 

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

●